C12N 2770/20032
Use of virus as therapeutic agent, other than vaccine
Official title: Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
C12N2770/20032 (Use of virus as therapeutic agent, other than vaccine) appears on 4 US grants and 13 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 13
- Assignees
- 18
- Inventors
- 44
- Latest grant
- 27 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 2 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 2 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 1 | 6 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Particles, DNA and RNA27 Jan 2026US 12,533,406 B2Novoscope IP Limited
- SARS-CoV-2 polypeptide inhibitors directed against the Env TM domain and methods of treatment using said inhibitors10 Jan 2023US 11,548,919 B1King Abdulaziz University
- Human Betacoronavirus lineage C and identification of N-terminal dipeptidyl peptidase as its virus receptor22 Sep 2020US 10,781,426 B2Dr. Soliman Fakeeh Hospital
- Canine respiratory coronavirus for treatment and protection against bacterial infections28 Apr 2020US 10,632,189 B2Zoetis Services LLC
- Compositions and methods for producing circular polyribonucleotides25 Jun 2026US 2026/0176637 A1Flagship Pioneering Innovations VI, LLC
- Therapeutic interfering particles for corona virus6 Nov 2025US 2025/0339508 A1The J. David Gladstone Institutes, a testamentary trust established under the Will of J. David Glad
- Lipopeptide fusion inhibitors as sars-cov-2 antivirals11 Jul 2024US 2024/0226304 A1Erasmus University Medical Center
- Particles, dna & rna2 Nov 2023US 2023/0346917 A1Novoscope IP Limited
- Method for in vitro proliferating virus belonging to family coronaviridae, method for producing neutralizing antibody to virus belonging to family coronaviridae, and method for producing infection model of severe acute respiratory syndrome coronavirus 27 Sep 2023US 2023/0279361 A1National University Corporation Shiga University of Medical Science
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.